Transenterix Inc (NASDAQ:TRXC)’s share price rose 17.4% on Monday . The company traded as high as $1.01 and last traded at $1.01. Approximately 1,452,913 shares changed hands during trading, an increase of 40% from the average daily volume of 1,039,300 shares. The stock had previously closed at $0.86.

TRXC has been the topic of a number of recent research reports. Zacks Investment Research upgraded Transenterix from a “hold” rating to a “buy” rating and set a $0.75 target price on the stock in a research note on Wednesday, May 10th. B. Riley lowered Transenterix to a “neutral” rating and set a $0.70 target price on the stock. in a research note on Tuesday, May 16th.

The firm has a 50-day moving average price of $0.74 and a 200 day moving average price of $0.85. The stock’s market cap is $150.02 million.

Large investors have recently bought and sold shares of the stock. LMR Partners LLP bought a new stake in shares of Transenterix in the 2nd quarter worth approximately $189,000. Global X Management Co. LLC raised its holdings in shares of Transenterix by 238.3% in the 2nd quarter. Global X Management Co. LLC now owns 331,075 shares of the company’s stock worth $235,000 after purchasing an additional 233,213 shares during the period. Royal Bank of Canada raised its holdings in shares of Transenterix by 17.1% in the 2nd quarter. Royal Bank of Canada now owns 418,867 shares of the company’s stock worth $298,000 after purchasing an additional 61,034 shares during the period. UBS Oconnor LLC bought a new stake in shares of Transenterix in the 2nd quarter worth approximately $390,000. Finally, Goldman Sachs Group Inc. raised its holdings in shares of Transenterix by 7,137.7% in the 2nd quarter. Goldman Sachs Group Inc. now owns 1,203,199 shares of the company’s stock worth $854,000 after purchasing an additional 1,186,575 shares during the period.

TRADEMARK VIOLATION WARNING: This piece of content was first published by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another site, it was stolen and reposted in violation of US & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/09/04/transenterix-inc-trxc-stock-price-up-17-4.html.

Transenterix Company Profile

TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.